SCP & CO has leveraged its expertise in healthcare and technology to take advantage of near-term market dynamics and favorable long-term secular trends in digital health by forming SCP & CO Healthcare Acquisition Company, a special purpose aquisition company, or SPAC.
There are two primary audiences who should educate themselves about SPAC’s
There are numerous advantages to high-growth, middle market businesses using a SPAC as its vehicle to access the public markets. While in the past, these special purpose acquisition companies were a seldom-used, rarely mentioned financial instrument, they have achieved broad market acceptance and are now a commonplace, if not preferred method of IPO.
An exit to the public markets is well-suited for high growth, middle-market companies that have received multiple rounds of venture capital funding. Additionally, there have been several successful spinoffs to SPAC’s of operating businesses within existing publicly-traded companies.
Since its inception in 2002, SCP& CO has completed eighty transactions totaling $1.8+ billion of aggregate transaction volume. Over half of the firm’s transactions have been platform acquisitions, financings, or add-on’s for SCP& CO’s Principals’ buyout control investment vehicles.